The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis

Psychological Medicine

Volumn 39, Issue 11, 2009, Pages 1783-1797

  Dutt, A ^a   McDonald, C ^b   Dempster, E ^a   Prata, D ^a   Shaikh, M ^a   Williams, I ^a   Schulze, K ^a   Marshall, N ^a   Walshe, M ^a   Allin, M ^a   Collier, D ^a   Murray, R ^a   Bramon, E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Bipolar; Endophenotypes; Genes; Hippocampus; Schizophrenia; Ventricles

Indexed keywords

5 HTT GENE; ADOLESCENT; ADULT; AGED; ARTICLE; BDNF GENE; BRAIN SIZE; COMT GENE; CONTROLLED STUDY; DTNBP1 GENE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NRG1 GENE; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEINS; CATECHOL O-METHYLTRANSFERASE; DOMINANCE, CEREBRAL; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HIPPOCAMPUS; HUMANS; LATERAL VENTRICLES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUREGULIN-1; ORGAN SIZE; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; REFERENCE VALUES; SCHIZOPHRENIA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 70449670963     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709990316     Document Type: Article

References (118)

1. Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jönsson EG (2006). BDNF gene variants and brain morphology in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 141, 513-523.
2. Badner JA, Gershon ES (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry 7, 405-411.
3. Bearden CE, Soares JC, Klunder AD, Nicoletti M, Dierschke N, Hayashi KM, Narr KL, Brambilla P, Sassi RB, Axelson D, Ryan N, Birmaher B, Thompson PM (2008). Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47, 515-525.
4. Boks MP, Leask S, Vermunt JK, Kahn RS (2007). The structure of psychosis revisited: the role of mood symptoms. Schizophrenia Research 93, 178-185.
5. Braff D, Schork NJ, Gottesman II (2007a). Endophenotyping schizophrenia. American Journal of Psychiatry 164, 705-707.
6. Braff DL, Freedman R, Schork NJ, Gottesman II (2007b). Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 33, 21-32.
7. Bramon E, Croft RJ, McDonald C, Virdi GK, Gruzelier JG, Baldeweg T, Sham PC, Frangou S, Murray RM (2004). Mismatch negativity in schizophrenia: a family study. Schizophrenia Research 67, 1-10.
8. Bramon E, Dempster E, Frangou S, McDonald C, Schoenberg P, MacCabe JH, Walshe M, Sham P, Collier D, Murray RM (2006). Is there any association between the COMT gene and P300 endophenotypes? European Psychiatry 21, 70-73.
9. Bramon E, Sham PC (2001). The common genetic liability between schizophrenia and bipolar disorder: a review. Current Psychiatry Reports 3, 332-337.
10. Breen G, Prata D, Osborne S, Munro J, Sinclair M, Li T, Staddon S, Dempster D, Sainz R, Arroyo B, Kerwin RW, St Clair D, Collier D (2006). Association of the dysbindin gene with bipolar affective disorder. American Journal of Psychiatry 163, 1636-1638.
11. Broome MR, Woolley JB, Tabraham P, Johns LC, Bramon E, Murray GK, Pariante C, McGuire PK, Murray RM (2005). What causes the onset of psychosis? Schizophrenia Research 79, 23-34.
12. Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, Malhotra AK (2007). DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophrenia Research 89, 169-172.
13. Cannon TD (2005). The inheritance of intermediate phenotypes for schizophrenia. Current Opinion in Psychiatry 18, 135-140.
14. Cannon TD, Keller MC (2006). Endophenotypes in the genetic analyses of mental disorders. Annual Review of Clinical Psychology 2, 267-290.
15. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002). A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry 159, 539-545.
16. Chakos MH, Schobel SA, Gu H, Gerig G, Bradford D, Charles C, Lieberman JA (2005). Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. British Journal of Psychiatry 186, 26-31.
17. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS (2004). Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Molecular Psychiatry 9, 962-967.
18. Cho HJ, Meira-Lima I, Cordeiro Q, Michelon L, Sham P, Vallada H, Collier DA (2005). Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Molecular Psychiatry 10, 771-781.
19. Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, Cheung JP, Yip L, Tai KS, Suckling J, McAlonan GM (2007). Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophrenia Research 89, 12-21. (Pubitemid 44895585)
20. Church SM, Cotter D, Bramon E, Murray RM (2002). Does schizophrenia result from developmental or degenerative processes? Journal of Neural Transmission 63 (Suppl.), S129-S147.
21. Craddock N, O'Donovan MC, Owen MJ (2006). Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bulletin 32, 9-16.
22. Craddock N, Owen MJ (2007). Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6, 84-91.
23. Craddock N, Owen MJ, O'Donovan MC (2006). The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Molecular Psychiatry 11, 446-458.
24. Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, Pérez-Iglesias R, Carrasco-Marín E, Mata I, González-Mandly A, Jorge R, Vázquez-Barquero JL (2007). Low-activity allele of catechol-O-methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosis. Progress in Neuro-psychopharmacology and Biological Psychiatry 31, 1514-1518.
25. Dean K, Bramon E, Murray RM (2003). The causes of schizophrenia: neurodevelopment and other risk factors. Journal of Psychiatric Practice 9, 442-454.
26. DeLisi LE (2008). The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophrenia Bulletin 34, 312-321.
27. Dempster E, Toulopoulou T, McDonald C, Bramon E, Walshe M, Filbey F, Wickham H, Sham PC, Murray RM, Collier DA (2005). Association between BDNF Val66 Met genotype and episodic memory. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 134, 73-75.
28. Dubertret C, Hanoun N, Adès J, Hamon M, Gorwood P (2005). Family-based association study of the 5-HT transporter gene and schizophrenia. International Journal of Neuropsychopharmacology 8, 87-92.
29. Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM (2007). Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin 33, 868-876.
30. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA 98, 6917-6922.
31. Endicott J, Spitzer RL (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35, 837-844.
32. Fan JB, Sklar P (2005). Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Molecular Psychiatry 10, 928-938. (Pubitemid 41486485)
33. Farmer A, Elkin A, McGuffin P (2007). The genetics of bipolar affective disorder. Current Opinion in Psychiatry 20, 8-12.
34. Frangou S, Sharma T, Sigmudsson T, Barta P, Pearlson G, Murray RM (1997). The Maudsley Family Study. 4. Normal planum temporale asymmetry in familial schizophrenia. A volumetric MRI study. British Journal of Psychiatry 170, 328-333.
35. Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, DeRosse P, Kane JM, Kucherlapati R (2005). COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behavioral and Brain Functions (http://www. behavioralandbrainfunctions.com/content/pdf/ 1744-9081-1-19.pdf). Accessed 28 July 2008.
36. Gelernter J, Kranzler H, Cubells JF (1997). Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African-and European-American and Japanese populations and in alcohol-dependent subjects. Human Genetics 101, 243-246.
37. Georgieva L, Dimitrova A, Ivanov D, Nikolov I, Williams NM, Grozeva D, Zaharieva I, Toncheva D, Owen MJ, Kirov G, O'Donovan MC (2008). Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biological Psychiatry 64, 419-427.
38. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160, 636-645.
39. Gruber O, Falkai P, Schneider-Axmann T, Schwab SG, Wagner M, Maier W (2008). Neuregulin-1 haplotype HAPICE is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. Journal of Psychiatric Research 43, 1-6.
40. Hajek T, Carrey N, Alda M (2005). Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disorders 7, 393-403.
41. Halliday GM (2001). A review of the neuropathology of schizophrenia. Clinical and Experimental Pharmacology and Physiology 28, 64-65.
42. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40-68.
43. Ho BC, Andreasen NC, Dawson JD, Wassink TH (2007). Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. American Journal of Psychiatry 164, 1890-1899.
44. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH (2006). Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 63, 731-740.
45. Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A, Kunugi H, Vallada H, Leigh PN, Chaudhuri KR, Collier DA (1996). No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochemical and Biophysical Research Communications 228, 780-784.
46. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Ozaki N (2006). No association of serotonin transporter gene (SLC6A4) with schizophrenia and bipolar disorder in Japanese patients: association analysis based on linkage disequilibrium. Journal of Neural Transmission 113, 899-905.
47. Ikeda M, Takahashi N, Saito S, Aleksic B, Watanabe Y, Nunokawa A, Yamanouchi Y, Kitajima T, Kinoshita Y, Kishi T, Kawashima K, Hashimoto R, Ujike H, Inada T, Someya T, Takeda M, Ozaki N, Iwata N (2008). Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. Schizophrenia Research 101, 1-8.
48. Isohanni M, Lauronen E, Moilanen K, Isohanni I, Kemppainen L, Koponen H, Miettunen J, Mäki P, Räsänen S, Veijola J, Tienari P, Wahlberg KE, Murray GK (2005). Predictors of schizophrenia: evidence from the Northern Finland 1966 Birth Cohort and other sources. British Journal of Psychiatry 48 (Suppl.), S4-S7. (Pubitemid 41139659)
49. Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS (2006). The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neuroscience Letters 407, 101-106.
50. Joo EJ, Lee KY, Jeong SH, Chang JS, Ahn YM, Koo YJ, Kim YS (2007). Dysbindin gene variants are associated with bipolar I disorder in a Korean population. Neuroscience Letters 418, 272-275.
51. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT (2007). Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatric Genetics 17, 165-170.
52. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM (2008). Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry 65, 1017-1032.
53. Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang Y (2004). Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? Journal of Psychiatric Research 38, 47-61.
54. Kumari V, Cooke M (2006). Use of magnetic resonance imaging in tracking the course and treatment of schizophrenia. Expert Review of Neurotherapeutics 6, 1005-1016.
55. Kwon OB, Longart M, Vullhorst D, Hoffman DA, Buonanno A (2005). Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. Journal of Neuroscience 225, 9378-9383.
56. Law A (2003). Schizophrenia, IV: neuregulin-1 in the human brain. American Journal of Psychiatry 160, 1392.
57. Lawrie SM, Abukmeil SS (1998). Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. British Journal of Psychiatry 172, 110-120.
58. Lawrie SM, Hall J, McIntosh AM, Cunningham-Owens DG, Johnstone EC (2008). Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential. British Journal of Pharmacology 153 (Suppl.), S120-S124.
59. Li D, Collier DA, He L (2006). Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Human Molecular Genetics 15, 1995-2002.
60. Lieberman JA (1999). Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biological Psychiatry 46, 729-739.
61. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62, 361-370.
62. Maier W (2008). Common risk genes for affective and schizophrenic psychoses. European Archives of Psychiatry and Clinical Neuroscience 2 (Suppl.), S37-S40.
63. Malaspina D (2006). Schizophrenia: a neurodevelopmental or a neurodegenerative disorder. Journal of Clinical Psychiatry 67, e07.
64. Mansour HA, Talkowski ME, Wood J, Pless L, Bamne M, Chowdari KV, Allen M, Bowden CL, Calabrese J, El-Mallakh RS, Fagiolini A, Faraone SV, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TA, Loftis JM, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Thase ME, Frank E, Kupfer DJ, Nimgaonkar VL (2005). Serotonin gene polymorphisms and bipolar 1 disorder: focus on the serotonin transporter. Annals of Medicine 37, 590-602.
65. Martorell L, Costas J, Valero J, Gutierrez-Zotes A, Phillips C, Torres M, Brunet A, Garrido G, Carracedo A, Guillamat R, Vallès V, Guitart M, Labad A, Vilella E (2008). Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophrenia Research 100, 308-315.
66. Massana G, Salgado-Pineda P, Junqué C, Pérez M, Baeza I, Pons A, Massana J, Navarro V, Blanch J, Morer A, Mercader JM, Bernardo M (2005). Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. Journal of Clinical Psychopharmacology 25, 111-117.
67. Mata I, Arranz MJ, Patiño A, Lai T, Beperet M, Sierrasesumaga L, Clark D, Perez-Nievas F, Richards L, Ortuño F, Sham P, Kerwin RW (2004). Serotonergic polymorphisms and psychotic disorders in populations from North Spain. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 126B, 88-94.
68. Mata I, Perez-Iglesias R, Roiz-Santiañez R, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Luis Vazquez-Barquero J, Crespo-Facorro B (2009). A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biological Psychiatry 65, 535-540.
69. McDonald C, Grech A, Toulopoulou T, Schulze K, Chapple B, Sham P, Walshe M, Sharma T, Sigmundsson T, Chitnis X, Murray RM (2002). Brain volumes in familial and non-familial schizophrenic probands and their unaffected relatives. American Journal of Medical Genetics (Neuropsychiatric Genetics) 114, 616-625.
70. McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B, Bramon E, Filbey F, Quraishi S, Walshe M, Murray RM (2006). Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. American Journal of Psychiatry 163, 478-487. (Pubitemid 44469391)
71. McDonald C, Zanelli J, Rabe-Hesketh S, Ellison-Wright I, Sham P, Kalidindi S, Murray RM, Kennedy N (2004). Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biological Psychiatry 56, 411-417.
72. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sánchez J, Pascau J, Desco M (2007). Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry 40, 135-139.
73. Morgan KD, Dazzan P, Orr KG, Hutchinson G, Chitnis X, Suckling J, Lythgoe D, Pollock SJ, Rossell S, Shapleske J, Fearon P, Morgan C, David A, McGuire PK, Jones PB, Leff J, Murray RM (2007). Grey matter abnormalities in first-episode schizophrenia and affective psychosis. British Journal of Psychiatry 51 (Suppl.), S111-S116. (Pubitemid 350273199)
74. Munafò MR, Bowes L, Clark TG, Flint J (2005). Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Molecular Psychiatry 10, 765-770.
75. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research 71, 405-416.
76. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 10, 208-212.
77. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. American Journal of Human Genetics 71, 651-655.
78. Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T (2007). No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neuroscience Research 58, 291-296.
79. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H (2006). The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129, 399-410.
80. Peper JS, Brouwer RM, Boomsma DI, Kahn RS, Hulshoff Pol HE (2007). Genetic influences on human brain structure: a review of brain imaging studies in twins. Human Brain Mapping 28, 464-473.
81. Peralta V, Cuesta MJ (2007). A dimensional and categorical architecture for the classification of psychotic disorders. World Psychiatry 6, 100-101.
82. Pfefferbaum A, Sullivan EV, Swan GE, Carmelli D (2000). Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiology of Aging 21, 63-74.
83. Prasad KM, Keshavan MS (2008). Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct 'extended endophenotypes'? Schizophrenia Bulletin 34, 774-790.
84. Prata DP, Breen G, Munro J, Sinclair M, Osborne S, Li T, Kerwin R, St Clair D, Collier DA (2006). Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatric Genetics 16, 229-230.
85. Reveley AM, Reveley MA, Chitkara B, Clifford C (1984). The genetic basis of cerebral ventricular volume. Psychiatry Research 13, 261-266.
86. Rijsdijk FV, van Haren NE, Picchioni MM, McDonald C, Toulopoulou T, Hulshoff Pol HE, Kahn RS, Murray R, Sham PC (2005). Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychological Medicine 35, 1399-1409.
87. Riley B, Kendler KS (2006). Molecular genetic studies of schizophrenia. European Journal of Human Genetics 14, 669-680.
88. Rosa A, Cuesta MJ, Fatjó-Vilas M, Peralta V, Zarzuela A, Fañanás L (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 141, 135-138.
89. Saleem Q, Ganesh S, Vijaykumar M, Reddy YC, Brahmachari SK, Jain S (2000). Association analysis of 5HT transporter gene in bipolar disorder in the Indian population. American Journal of Medical Genetics (Neuropsychiatric Genetics) 96, 170-172.
90. Sand PG, Eichhammer P, Langguth B, Hajak G (2006). COMT association data in schizophrenia: new caveats. Biological Psychiatry 60, 663-664.
91. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A, Rozic P, Vinogradov S, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Crowe RR, Cloninger CR, Martinez M, Gejman PV (2008). No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. American Journal of Psychiatry 165, 497-506.
92. Scherk H, Falkai P (2006). Effects of antipsychotics on brain structure. Current Opinion in Psychiatry 19, 145-150.
93. Schulze K, McDonald C, Frangou S, Sham P, Grech A, Toulopoulou T, Walshe M, Sharma T, Sigmundsson T, Taylor M, Murray RM (2003). Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives. Biological Psychiatry 53, 562-570.
94. Seidman LJ, Faraone SV, Goldstein JM, Kremen WS, Horton NJ, Makris N, Toomey R, Kennedy D, Caviness VS, Tsuang MT (2002). Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Archives of General Psychiatry 59, 839-849.
95. Seidman LJ, Wencel HE (2003). Genetically mediated brain abnormalities in schizophrenia. Current Psychiatry Report 5, 135-144.
96. Shenton ME, Dickey CC, Frumin M, McCarley RW (2001). A review of MRI findings in schizophrenia. Schizophrenia Research 49, 1-52.
97. Shi J, Gershon ES, Liu C (2008). Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophrenia Research 104, 96-107.
98. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Molecular Psychiatry 7, 579-593.
99. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA (2006). Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry 188, 510-518.
100. Stefanis N, Frangou S, Yakeley J, Sharma T, O'Connell P, Morgan K, Sigmundsson T, Taylor M, Murray RM (1999). Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biological Psychiatry 46, 697-702.
101. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, Ingason A, Gulcher JR, Stefansson K, St Clair D (2003). Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. American Journal of Human Genetics 72, 83-87.
102. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 71, 877-892.
103. Strasser HC, Lilyestrom J, Ashby ER, Honeycutt NA, Schretlen DJ, Pulver AE, Hopkins RO, Depaulo JR, Potash JB, Schweizer B, Yates KO, Kurian E, Barta PE, Pearlson GD (2005). Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study. Biological Psychiatry 57, 633-639.
104. Styner M, Lieberman JA, McClure RK, Weinberger DR, Jones DW, Gerig G (2005). Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors. Proceedings of the National Academy of Sciences USA 102, 4872-4877.
105. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, Goldman D, Malhotra AK (2005). Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Molecular Psychiatry 10, 631-636.
106. Taylor WD, Züchner S, Payne ME, Messer DF, Doty TJ, MacFall JR, Beyer JL, Krishnan KR (2007). The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. Psychiatry Research 155, 173-177.
107. Tunbridge EM, Harrison PJ, Weinberger DR (2006). Catechol-o- methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry 60, 141-151.
108. Walterfang M, Wood SJ, Velakoulis D, Pantelis C (2006). Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neuroscience and Biobehavioral Reviews 30, 918-948.
109. Wang PW, Ketter TA (2000). Biology and recent brain imaging studies in affective psychoses. Current Psychiatry Reports 2, 298-304.
110. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, Herman MM, Weinberger DR, Kleinman JE (2004). Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Archives of General Psychiatry 61, 544-555.
111. Whitworth AB, Kemmler G, Honeder M, Kremser C, Felber S, Hausmann A, Walch T, Wanko C, Weiss EM, Stuppaeck CH, Fleischhacker WW (2005). Longitudinal volumetric MRI study in first-and multiple-episode male schizophrenia patients. Psychiatry Research 140, 225-237.
112. Wickham H, Murray RM (1997). Can biological markers identify endophenotypes predisposing to schizophrenia ? International Review of Psychiatry 9, 355-364.
113. Williams HJ, Glaser B, Williams NM, Norton N, Zammit S, MacGregor S, Kirov GK, Owen MJ, O'Donovan MC (2005). No association between schizophrenia and polymorphisms in COMT in two large samples. American Journal of Psychiatry 162, 1736-1738.
114. Williams HJ, Owen MJ, O'Donovan MC (2007). Is COMT a susceptibility gene for schizophrenia? Schizophrenia Bulletin 33, 635-641.
115. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S, O'Donovan MC, Owen MJ (2003). Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Molecular Psychiatry 8, 485-487.
116. Wood SJ, Pantelis C, Velakoulis D, Yücel M, Fornito A, McGorry PD (2008). Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin 34, 322-329.
117. Wood SJ, Velakoulis D, Smith DJ, Bond D, Stuart GW, McGorry PD, Brewer WJ, Bridle N, Eritaia J, Desmond P, Singh B, Copolov D, Pantelis C (2001). A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophrenia Research 52, 37-46.
118. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157, 16-25.